Partner Kenny Broodo is quoted in an article in Inyan, “Elevenfold Baalei Tzedakah,” about charitable and philanthropic activities he’s involved in.
Broodo does a variety of pro bono legal work for the Torah Day School and Mesorah High School in Dallas. “The technical work is part of what I do, and I’m happy to do it. It’s the heart-wrenching personal conflicts that are difficult. And I feel the weight of it. But we work and try our best to do the right thing…for the families first, but also the mosdos.”
In addition to his pro bono work, Broodo also volunteers as a fund-raiser for Congregation Ohr Ha Torah of Dallas. “You have to find the courage to go ahead and ask, and to know that even when you get a ‘no,’ you’ve done better than not asking,” he said.
Broodo does a variety of pro bono legal work for the Torah Day School and Mesorah High School in Dallas. “The technical work is part of what I do, and I’m happy to do it. It’s the heart-wrenching personal conflicts that are difficult. And I feel the weight of it. But we work and try our best to do the right thing…for the families first, but also the mosdos.”
In addition to his pro bono work, Broodo also volunteers as a fund-raiser for Congregation Ohr Ha Torah of Dallas. “You have to find the courage to go ahead and ask, and to know that even when you get a ‘no,’ you’ve done better than not asking,” he said.
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”